COMPASS Pathways
A London-based biotechnology company developing COMP360, an investigational synthetic psilocybin treatment, through a global phase 3 programme in treatment-resistant depression.
0 jobs
Jobs
No jobs match — try clearing a filter.
A London-based biotechnology company developing COMP360, an investigational synthetic psilocybin treatment, through a global phase 3 programme in treatment-resistant depression.
0 jobs